Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-03T03:05:31.628Z Has data issue: false hasContentIssue false
  • English
  • Français

Endocrine and behavioural responses to methylphenidate in depression

Published online by Cambridge University Press:  09 July 2009

Peter R. Joyce ,
Richard A. Donald ,
M. Gary Nicholls ,
John H. Livesey  and
Robyn M. Abbott
Peter R. Joyce*
Affiliation:
Sunnyside Hospital, Christchurch, Department of Endocrinology, The Princess Margaret Hospital, Christchurch, New Zealand
Richard A. Donald
Affiliation:
Sunnyside Hospital, Christchurch, Department of Endocrinology, The Princess Margaret Hospital, Christchurch, New Zealand
M. Gary Nicholls
Affiliation:
Sunnyside Hospital, Christchurch, Department of Endocrinology, The Princess Margaret Hospital, Christchurch, New Zealand
John H. Livesey
Affiliation:
Sunnyside Hospital, Christchurch, Department of Endocrinology, The Princess Margaret Hospital, Christchurch, New Zealand
Robyn M. Abbott
Affiliation:
Sunnyside Hospital, Christchurch, Department of Endocrinology, The Princess Margaret Hospital, Christchurch, New Zealand
*
1Address for correspondence: Dr P. R. Joyce, Sunnyside Hospital, Christchurch, New Zealand
Get access Rights & Permissions [Opens in a new window]

Synopsis

Twenty patients with a major depressive disorder and 20 control subjects were subjected to a 1 mg dexamethasone suppression test (DST) and a challenge with intravenous (IV) methylphenidate (MP)(0·3 mg/kg). None of the controls, but 9 depressives, were DST non-suppressors. Among the depressives there were correlations between DST-cortisol and baseline (4 p.m.) levels of cortisol, growth hormone, prolactin and adrenaline. Compared with the controls the depressives had a decreased cortisol response and an enhanced adrenaline response to the MP challenge. The decreased cortisol response was not related to either DST-cortisol or baseline cortisol, but was correlated with the mood response to MP.

Type
Research Article
Information
Psychological Medicine , Volume 16 , Issue 3 , August 1986 , pp. 531 - 540
Copyright
Copyright © Cambridge University Press 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akiskal, H. S. (1983). Dysthymic disorder: psychopathology of proposed chronic depressive subtypes. American Journal of Psychiatry 140, 11–20.Google ScholarPubMed
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd edn). APA: Washington D.C.Google Scholar
Axelrod, J. & Reisine, T. D. (1984). Stress hormones: their interaction and regulation. Science 224, 452–459.CrossRefGoogle ScholarPubMed
Barnes, R. F., Veitch, R. C., Borson, S., Verhey, J., Raskind, M. A. & Halter, J. B. (1983). High levels of plasma catecholamines in dexamethasone-resistant depressed patients. American Journal of Psychiatry 140, 1623–1625.Google ScholarPubMed
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561–571.CrossRefGoogle ScholarPubMed
Brown, P. & Brawley, P. (1983). Dexamethasone suppression test and mood response to methylphenidate in primary depression. American Journal of Psychiatry 140, 990–993.Google ScholarPubMed
Brown, W. A. (1977), Psychologic and neuroendocrine response to methylphenidate. Archives of General Psychiatry 34, 1103–1108.CrossRefGoogle ScholarPubMed
Brown, W. A., Corrivean, D. P. & Ebert, M. H. (1978). Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate. Psychopharmacology 58, 189–195.CrossRefGoogle ScholarPubMed
Carney, M. W. P., Roth, M. & Garside, R. F. (1965). The diagnosis of depressive syndromes and the prediction of ECT response. British Journal of Psychiatry 111, 659–674.CrossRefGoogle Scholar
Carroll, B. J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A. A., Haskett, R. F., James, N. M., Kronfol, Z., Lohr, N., Steiner, M., deVigne, J. P. Vigne, J. P. & Young, E. (1981). A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Archives of General Psychiatry 38, 15–22.CrossRefGoogle ScholarPubMed
Checkley, S. A. (1979). Corticosteroid and growth hormone responses to methylamphetamine in depressive illness. Psychological Medicine 9, 107–115.CrossRefGoogle ScholarPubMed
Checkley, S. A. & Crammer, J. L. (1977). Hormone response to methylamphetamine in depression: a new approach to the noradrenaline depletion hypothesis. British Journal of Psychiatry 131, 582–586.CrossRefGoogle Scholar
Clemens, J. A. & Fuller, R. W. (1979). Differences in the effects of amphetamine and methylphenidate on brain dopamine turnover and serum prolactin concentration in reserpine-treated rats. Life Sciences 24, 2077–2082.CrossRefGoogle ScholarPubMed
Corn, T. H., Hale, A. S., Thompson, C., Bridges, P. K. & Checkley, S. A. (1984). A comparison of the growth hormone response to clonidine and apomorphine in the same patients with endogenous depression. British Journal of Psychiatry 144, 636–639.CrossRefGoogle ScholarPubMed
Davidson, J., Turnbull, C., Strickland, R. & Belyea, M. (1984). Comparative diagnostic criteria for melancholia and endogenous depression. Archives of General Psychiatry 41, 506–511.CrossRefGoogle ScholarPubMed
Ettigi, P. G., Hayes, P. E., Narasimhachari, N., Hamer, R. M., Goldberg, S. & Secord, G. J. (1983). D-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression. Biological Psychiatry 18, 499–504.Google ScholarPubMed
Fawcett, J., Maas, J. W. & Dekirmengian, H. (1972). Depression and MHPG excretion: response to dextroamphetamine and tricyclic anti-depressants. Archives of General Psychiatry 26, 246–251.CrossRefGoogle Scholar
Feinberg, M. & Carroll, B. J. (1982). Separation of subtypes of depression using discriminant analysis. I. Separation of unipolar endogenous depression. British Journal of Psychiatry 140, 384–391.CrossRefGoogle ScholarPubMed
Feinberg, M., Greden, J. F. & Carroll, B. J. (1981). The effect of amphetamine on plasma cortisol in patients with endogenous and non-endogenous depression. Psychoneuroendocrinology 6, 355–357.CrossRefGoogle ScholarPubMed
Goldstein, D. S., Nurnberger, J., Simmons, S., Gershon, E. S., Polinsky, R. & Keiser, H. R. (1983). Effects of injected sympathomimeticamines on plasma catecholamines and circulatory variables in man. Life Sciences 32, 1057–1063.CrossRefGoogle Scholar
Halbreich, U., Sachar, E. J., Asnis, G. M., Quitkin, F., Nathan, R. S., Halpern, F. S. & Klein, D. F. (1982). Growth hormone response to dextro-amphetamine in depressed patients and normal subjects. Archives of General Psychiatry 39, 189–192.CrossRefGoogle ScholarPubMed
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56–62.CrossRefGoogle ScholarPubMed
Joyce, P. R. (1985). Mood response to methylphenidate and the dexamethasone suppression test as predictors of treatment response to zimelidine and lithium in major depression. Biological Psychiatry 20, 598–604.CrossRefGoogle ScholarPubMed
Joyce, P. R., Nicholls, M. G. & Donald, R. A. (1984). Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects. Life Sciences 34, 1707–1711.CrossRefGoogle ScholarPubMed
Joyce, P. R., Donald, R. A. & Livesey, J. H. (1985). A relationship between prolactin levels and the dexamethasone suppression test results in major depressive disorder. Journal of Affective Disorders 8, 191–195.CrossRefGoogle ScholarPubMed
Judd, L. L., Parker, D. C., Janowsky, D. S., Segal, D. S., Risch, S. C. & Huey, L. Y. (1982). The effect of methadone on the behavioural and neuroendocrine responses of manic patients. Psychiatry Research 7, 163–170.CrossRefGoogle ScholarPubMed
Kiloh, L. G., Neilson, M. & Andrews, G. (1974). Response of depressed patients to methylamphetamine. British Journal of Psychiatry 125, 496–499.CrossRefGoogle ScholarPubMed
Langer, G., Heinze, G., Reim, B. & Matussek, N. (1976). Reduced growth hormone responses to amphetamine in ‘endogenous’ depressive patients. Archives of General Psychiatry 33, 1471–1475.CrossRefGoogle ScholarPubMed
Livesey, J. H. & Donald, R. A. (1982). Prevention of absorption losses during radioimmunoassay of polypeptide hormones: effectiveness of albium etc. Clinica Chimica Acta 123, 193–198.CrossRefGoogle Scholar
Livesey, J. H., Donald, R. A., Espiner, E. A. & Salamonsen, L. A. (1972). Measurement of pituitary hormones: clinical applications. 3. Growth hormone. New Zealand Medical Journal 76, 261–264.Google ScholarPubMed
Maas, J. W. (1978). Clinical and biochemical heterogeneity of depressive disorders. Annals of Internal Medicine 88, 556–563.CrossRefGoogle ScholarPubMed
Nurnberger, J. I., Gershon, E. S., Simmons, S., Ebert, M., Kessler, L. R., Dibble, E. D., Jimeson, S. S., Brown, G. M., Gold, P., Jimerson, D. C., Guroff, J. J. & Starch, F. I. (1982). Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients. Psychoneuro-endocrinology 7, 163–176.CrossRefGoogle ScholarPubMed
Peuler, J. D. & Johnson, G. A. (1977). Simultaneous single isotope radio-enzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sciences 21, 625–633.CrossRefGoogle Scholar
Rees, L., Butler, P. W. P., Gosling, C. & Besser, G. M. (1970). Adrenergic blockade and the corticosteroid and growth hormone response to methylamphetamine. Nature 228, 565–566.CrossRefGoogle ScholarPubMed
Roberts, J. M. (1959). Prognostic factors in the electroshock treatment of depressive states. II. The application of specific tests. Journal of Mental Sciences 105, 703–713.CrossRefGoogle ScholarPubMed
Rothschild, A. J., Schatzberg, A. F., Rosenbaum, A. H., Stahl, J. B. & Cole, J. O. (1982). The dexamethasone suppression test as a discriminant among subtypes of psychotic patients. British Journal of Psychiatry 141, 471–474.CrossRefGoogle ScholarPubMed
Roy-Byrne, P. P., Gwirtsman, H. E., Baxter, L. & Gerner, R. H. (1983). Endocrine correlates of mood response to methylphenidate in depression. Journal of Clinical Psychopharmacology 3, 266–268.CrossRefGoogle ScholarPubMed
Ruder, H. J., Guy, R. L. & Lipsett, M. B. (1972). A radioimmunoassay for cortisol in plasma and urine. Journal of Clinical Endocrinology and Metabolism 35, 219–224.CrossRefGoogle ScholarPubMed
Sachar, E. J., Asnis, G., Nathan, R. S., Halbreich, U., Tabrizi, M. A. & Halpern, F. S. (1980). Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed. Archives of General Psychiatry 37, 755–757.CrossRefGoogle ScholarPubMed
Sachar, E. J., Halbreich, U., Asnis, G. M., Nathan, R. S., Halpern, F. S. & Ostrow, L. (1981). Paradoxical cortisol responses to dextroamphetamine in endogenous depression. Archives of General Psychiatry 38, 1113–1117.CrossRefGoogle ScholarPubMed
Schatzberg, A. F., Rothschild, A. J., Stahl, J. B., Bond, T. C., Rosenbaum, A. H., Lofgren, S. B., MacLaughlin, R. A., Sullivan, M. A. & Cole, J. O. (1983). The dexamethasone suppression test: identification of subtypes of depression. American Journal of Psychiatry 140, 88–91.Google ScholarPubMed
Silberman, E. K., Reus, V. I., Jimerson, D. C., Lynott, A. M. & Post, R M. (1981). Heterogeneity of amphetamine response in depressed patients. American Journal of Psychiatry 138, 1302–1307.Google ScholarPubMed
Smith, R. C. & Davis, J. M. (1977). Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man. Psychopharmacology 53, 1–12.CrossRefGoogle ScholarPubMed
Sternback, H., Gwirtsman, H. & Gerner, R. H. (1981). The dexamethasone suppression test and response to methylphenidate in depression. American Journal of Psychiatry 138, 1629–1631.Google Scholar
Stewart, J. W., Quitkin, F., McGrath, P. J., Liebowitz, M. R., Harrison, W., Rabkin, J. G., Novacenko, H., Puig-Antich, J. & Asnis, G. M. (1984). Cortisol response to dextroamphetamine stimulation in depressed outpatients. Psychiatry Research 12, 195–206.CrossRefGoogle ScholarPubMed
Van Kammen, D. P. & Murphy, D. L. (1978). Prediction of imipramine antidepressant response by a one-day d-amphetamine trial. American Journal of Psychiatry 135, 1179–1184.Google ScholarPubMed
Van Kammen, D. P. & Murphy, D. L. (1979). Prediction of antidepressant response to lithium carbonate by a 1-day administration of d-amphetamine in unipolar depressed women. Neuropsychobiology 5, 266–273.CrossRefGoogle ScholarPubMed
Weissman, M. M., Wickramaratne, P., Merikangas, K. R., Leckman, J. F., Prusoff, B. A., Caruso, K. A., Kidd, K. K. & Gammon, G. D. (1984). Onset of major depression in early adulthood. Increased familial loading and specificity. Archives of General Psychiatry 41, 1136–1143.CrossRefGoogle ScholarPubMed